Evidence map›Paper›PMID 23326250›Full record

ArticleMolecular syndromology2012

Genetic dissection of marfan syndrome and related connective tissue disorders: an update 2012.

S Hoffjan

Open access · bronzeAbstract read
In one paragraph

Article in Molecular syndromology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Rare Variants and Polymorphisms ofFrontiers in genetics · 2022
    Article
  4. Article
  5. Article
  6. Journal of the American Heart Association · 2021
    Article
  7. Review
  8. Genetic Evaluation, Familial Screening and Exercise.Arquivos brasileiros de cardiologia · 2017
    Review
  9. Shprintzen-Goldberg syndrome: a rare disorder.The Pan African medical journal · 2016
    Review
  10. Marfan syndrome: current perspectives.The application of clinical genetics · 2016
    Review
  11. Article
  12. A novel mutation in fibrillin-1 gene identified in a Chinese family with marfan syndrome.International journal of clinical and experimental medicine · 2015
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

S HoffjanDepartment of Human Genetics, Ruhr-University, Bochum, Germany.
Ruhr University Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marfan syndrome (MFS) is an autosomal dominant disorder of the connective tissue characterized by early development of thoracic aortic aneurysms/dissections together with symptoms of the ocular and skeletal systems. While most patients/families with a classic phenotypic expression of MFS harbour mutations in the gene encoding fibrillin-1 (FBN1), genetic studies of the recent years revealed that the clinical features, as well as the mutated genes, show a high degree of overlap between MFS and other connective tissue diseases (e.g. Loeys-Dietz syndrome, Ehlers-Danlos syndrome, familial thoracic aneurysms and dissections and others). We summarize herein the current knowledge about the wide spectrum of differential diagnoses and their genetic background as well as novel therapeutic approaches in order to provide appropriate counselling and clinical follow-up for the patients.

Indexed as

Connective tissue disordersEhlers-Danlos syndromeLoeys-Dietz syndromeMarfan syndrome

Identifiers

PMID23326250
PMCPMC3542934
OpenAlexW1973282283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.